Search

everythinglearnresearchcommunity

for

Search:↓

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Healthy scalp reduces hair loss by managing oxidative stress.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Some drugs can cause changes to your hair.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.